Latest Health News

EVE Health Group has completed its acquisition of Nextract Pty Ltd, positioning itself to enter the lucrative erectile dysfunction and dysmenorrhea markets with innovative drug delivery technologies.

dorsaVi has secured exclusive worldwide rights to cutting-edge RRAM technology from NTU Singapore, promising to revolutionize its wearable sensor products with enhanced performance and energy efficiency. This strategic move positions the company for expansion into healthcare, elite sports, and industrial IoT markets.

AdNeo Limited’s shares are back on the ASX following the completion of a capital raising, ending a trading suspension that had investors waiting. The biotech company’s next moves will be closely watched as it seeks to leverage fresh funds.

EVE Health Group has launched a $1.5 million capital raise alongside the acquisition of biotech firm Nextract, aiming to expand its footprint in health and pharmaceutical products focused on erectile dysfunction and period pain.

Hawsons Iron Limited has voluntarily suspended trading on the ASX as it prepares to announce a proposed capital raising, signaling a pivotal moment for the iron ore miner.

Norwood Systems has successfully delivered a crucial software milestone under a major telecom contract, while also reporting strong customer receipts that bolster its cash position.

Olympus Corporation has launched a nationwide emphysema screening campaign in the US powered by 4DMedical’s AI lung density analysis, marking a major commercial milestone for the Australian medtech firm.

GQG Partners has reported a steady rise in funds under management, reaching US$168.5 billion by the end of May 2025, supported by robust net inflows across key equity strategies.

Mineral Commodities Ltd reveals delays in receiving the final payment for its Skaland Graphite Project sale, with interest rates on outstanding amounts now sharply increased.

Careteq Limited has raised $625,000 through a convertible note from investor Antanas Guoga and loans from its board, strengthening its working capital position for the medium term.

Little Green Pharma invites shareholders to a detailed FY2025 financial results webinar, promising insights into profitability, revenue growth, and recent financing achievements.

HyTerra Limited has successfully completed the Blythe 13-20 well at its Nemaha Project, confirming promising hydrogen and helium presence and expanding its drilling program to three wells.